1: Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S. Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure. Food Chem Toxicol. 2018 Apr;114:215-226. doi: 10.1016/j.fct.2018.02.036. Epub 2018 Feb 16. PubMed PMID: 29458164.
2: He X, Xia Q, Woodling K, Lin G, Fu PP. Pyrrolizidine alkaloid-derived DNA adducts are common toxicological biomarkers of pyrrolizidine alkaloid N-oxides. J Food Drug Anal. 2017 Oct;25(4):984-991. doi: 10.1016/j.jfda.2017.09.001. Epub 2017 Sep 19. PubMed PMID: 28987376.
3: Huybrechts B, Callebaut A. Pyrrolizidine alkaloids in food and feed on the Belgian market. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(11):1939-51. doi: 10.1080/19440049.2015.1086821. Epub 2015 Oct 15. PubMed PMID: 26373269.
4: Luckert C, Hessel S, Lenze D, Lampen A. Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. Toxicol In Vitro. 2015 Oct;29(7):1669-82. doi: 10.1016/j.tiv.2015.06.021. Epub 2015 Jun 20. PubMed PMID: 26100227.
5: Field RA, Stegelmeier BL, Colegate SM, Brown AW, Green BT. An in vitro comparison of the cytotoxic potential of selected dehydropyrrolizidine alkaloids and some N-oxides. Toxicon. 2015 Apr;97:36-45. doi: 10.1016/j.toxicon.2015.02.001. Epub 2015 Feb 7. PubMed PMID: 25666399.
6: Shimshoni JA, Mulder PP, Bouznach A, Edery N, Pasval I, Barel S, Abd-El Khaliq M, Perl S. Heliotropium europaeum poisoning in cattle and analysis of its pyrrolizidine alkaloid profile. J Agric Food Chem. 2015 Feb 11;63(5):1664-72. doi: 10.1021/jf5052199. Epub 2015 Jan 27. PubMed PMID: 25591008.
7: Zhao Y, Wang S, Xia Q, Gamboa da Costa G, Doerge DR, Cai L, Fu PP. Reaction of dehydropyrrolizidine alkaloids with valine and hemoglobin. Chem Res Toxicol. 2014 Oct 20;27(10):1720-31. doi: 10.1021/tx5002139. Epub 2014 Sep 11. PubMed PMID: 25211425.
8: Hessel S, Gottschalk C, Schumann D, These A, Preiss-Weigert A, Lampen A. Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine. Mol Nutr Food Res. 2014 May;58(5):995-1004. doi: 10.1002/mnfr.201300707. Epub 2013 Dec 27. PubMed PMID: 24375927.
9: Oplatowska M, Elliott CT, Huet AC, McCarthy M, Mulder PP, von Holst C, Delahaut P, Van Egmond HP, Campbell K. Development and validation of a rapid multiplex ELISA for pyrrolizidine alkaloids and their N-oxides in honey and feed. Anal Bioanal Chem. 2014 Jan;406(3):757-70. doi: 10.1007/s00216-013-7488-7. Epub 2013 Dec 11. PubMed PMID: 24327075.
10: Xia Q, Zhao Y, Von Tungeln LS, Doerge DR, Lin G, Cai L, Fu PP. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity. Chem Res Toxicol. 2013 Sep 16;26(9):1384-96. doi: 10.1021/tx400241c. Epub 2013 Aug 26. PubMed PMID: 23937665.
11: Tamta H, Pawar RS, Wamer WG, Grundel E, Krynitsky AJ, Rader JI. Comparison of metabolism-mediated effects of pyrrolizidine alkaloids in a HepG2/C3A cell-S9 co-incubation system and quantification of their glutathione conjugates. Xenobiotica. 2012 Oct;42(10):1038-48. doi: 10.3109/00498254.2012.679978. Epub 2012 Apr 23. PubMed PMID: 22519982.
12: Xia Q, Yan J, Chou MW, Fu PP. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine. Toxicol Lett. 2008 May 5;178(2):77-82. doi: 10.1016/j.toxlet.2008.02.008. Epub 2008 Mar 4. PubMed PMID: 18395999.
13: Cosmetic Ingredient Review Expert Panel. Final report of the safety assessment of niacinamide and niacin. Int J Toxicol. 2005;24 Suppl 5:1-31. Review. PubMed PMID: 16596767.
14: Sanderson BJ, Clark AM. Micronuclei in adult and foetal mice exposed in vivo to heliotrine, urethane, monocrotaline and benzidine. Mutat Res. 1993 Jan;285(1):27-33. PubMed PMID: 7678129.
15: Moore DJ, Batts KP, Zalkow LL, Fortune GT Jr, Powis G. Model systems for detecting the hepatic toxicity of pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides. Toxicol Appl Pharmacol. 1989 Nov;101(2):271-84. PubMed PMID: 2815083.
16: Lieber MM, Ames MM, Powis G, Kovach JS. Anticancer drug testing in vitro: use of an activating system with the human tumor stem cell assay. Life Sci. 1981 Jan 19;28(3):287-93. PubMed PMID: 7219049.
17: Peterson JE, Jago MV. Comparison of the toxic effects of dehydroheliotridine and heliotrine in pregnant rats and their embryos. J Pathol. 1980 Aug;131(4):339-55. PubMed PMID: 7431152.
18: Evans JV, Daley SK, McClusky GA, Nielsen CJ. Direct quantitative analysis of indicine-N-oxide in cancer patient samples by gas chromatography using the internal standard heliotrine-N-oxide including a mass spectral comparison of their trimethylsilyl derivatives. Biomed Mass Spectrom. 1980 Feb;7(2):65-73. PubMed PMID: 7407334.
19: Powis G, Ames MM, Kovach JS. Relationship of the reductive metabolism of indicine N-oxide to its antitumor activity. Res Commun Chem Pathol Pharmacol. 1979 Jun;24(3):559-69. PubMed PMID: 451340.
20: Evans JV, Peng A, Nielsen CJ. The gas chromatographic mass spectrometric analysis of the new antitumor drug indicine-N-oxide utilizing a novel reaction accompanying trimethylsilylation. Biomed Mass Spectrom. 1979 Jan;6(1):38-43. PubMed PMID: 427260.